🟢 LLY is trading 4% up today on news of acquiring Centessa Pharmaceuticals and expanding its AI drug discovery partnership

LLY is trading at $923.60 (+4.17%) following two significant company-specific announcements that overshadowed broader market trends.

• Acquisition of Centessa Pharmaceuticals: Eli Lilly announced a definitive agreement to acquire Centessa Pharmaceuticals for $38.00 per share in cash, with a potential for an additional $9.00 per share, valuing the deal at up to $47.00 per share. This move is set to expand Lilly's neuroscience pipeline with treatments for sleep-wake disorders.
• Expanded AI Partnership: The company also expanded its AI-powered drug discovery collaboration with Insilico Medicine in a deal potentially worth up to $2.75 billion, aiming to accelerate the development of new therapeutics.
• Broader Market Context: These company-specific catalysts were further supported by a positive market sentiment, with the S&P 500 up +1.63% and the NASDAQ rising +2.22% amid hopes of geopolitical de-escalation and reassuring comments from the Federal Reserve.